News
Oncologist who served as FDA’s chief medical officer, top vaccine official departs agency
A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the agency.HHS confirmed the departure of Vinay K. Prasad, MD, MPH, providing the following statement to Healio: “Dr.
Investing.com -- Novo Nordisk (NYSE: NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...
Illinois Gov. JB Pritzker and former U.S. Commerce Secretary Penny Pritzker are at the center of an effort to drive more ...
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...
The House Judiciary Committee ordered Dr. Philip Dormitzer, the ex-vice president and chief scientific officer of RNA and viral vaccines for Pfizer, to appear for a deposition on July 22.
Dr. Hodous, chief scientific officer, noted, “It has been deeply gratifying to witness the evolution of what began as a formidable scientific challenge—targeting SH2 domains as a therapeutic ...
NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment, with Melbourne-based exec Nathan Smith ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback